Rapid outpatient transient ischemic attack clinic and stroke service activity during the SARS-CoV-2 pandemic: a multicenter time series analysis.

SARS-CoV-2 TIA TIA clinic stroke time series analysis

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2024
Historique:
received: 07 12 2023
accepted: 23 01 2024
medline: 22 2 2024
pubmed: 22 2 2024
entrez: 22 2 2024
Statut: epublish

Résumé

Rapid outpatient evaluation and treatment of TIA in structured clinics have been shown to reduce stroke recurrence. It is unclear whether short-term downtrends in TIA incidence and admissions have had enduring impact on TIA clinic activity. This study aims to measure the impact of the pandemic on hospitals with rapid TIA clinics. Relevant services were identified by literature search and contacted. Three years of monthly data were requested - a baseline pre-COVID period (April 2018 to March 2020) and an intra-COVID period (April 2020 to March 2021). TIA presentations, ischemic stroke presentations, and reperfusion trends inclusive of IV thrombolysis (IVT) and endovascular thrombectomy (EVT) were recorded. Pandemic impact was measured with interrupted time series analysis, a segmented regression approach to test an effect of an intervention on a time-dependent outcome using a defined impact model. Six centers provided data for a total of 6,231 TIA and 13,191 ischemic stroke presentations from Australia (52.1%), Canada (35.0%), Italy (7.6%), and England (5.4%). TIA clinic volumes remained constant during the pandemic (2.9, 95% CI -1.8 to 7.6, This suggests that the pandemic has not had an enduring effect on TIA clinic or stroke service activity for these centers. Furthermore, the disproportionate decrease in IVT suggests that patients may be presenting outside the IVT window during the pandemic - delays in seeking treatment in this group could be the target for public health intervention.

Sections du résumé

Background and aim UNASSIGNED
Rapid outpatient evaluation and treatment of TIA in structured clinics have been shown to reduce stroke recurrence. It is unclear whether short-term downtrends in TIA incidence and admissions have had enduring impact on TIA clinic activity. This study aims to measure the impact of the pandemic on hospitals with rapid TIA clinics.
Methods UNASSIGNED
Relevant services were identified by literature search and contacted. Three years of monthly data were requested - a baseline pre-COVID period (April 2018 to March 2020) and an intra-COVID period (April 2020 to March 2021). TIA presentations, ischemic stroke presentations, and reperfusion trends inclusive of IV thrombolysis (IVT) and endovascular thrombectomy (EVT) were recorded. Pandemic impact was measured with interrupted time series analysis, a segmented regression approach to test an effect of an intervention on a time-dependent outcome using a defined impact model.
Results UNASSIGNED
Six centers provided data for a total of 6,231 TIA and 13,191 ischemic stroke presentations from Australia (52.1%), Canada (35.0%), Italy (7.6%), and England (5.4%). TIA clinic volumes remained constant during the pandemic (2.9, 95% CI -1.8 to 7.6,
Conclusion UNASSIGNED
This suggests that the pandemic has not had an enduring effect on TIA clinic or stroke service activity for these centers. Furthermore, the disproportionate decrease in IVT suggests that patients may be presenting outside the IVT window during the pandemic - delays in seeking treatment in this group could be the target for public health intervention.

Identifiants

pubmed: 38385034
doi: 10.3389/fneur.2024.1351769
pmc: PMC10879819
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1351769

Informations de copyright

Copyright © 2024 Lim, Rothwell, Li, Coutts, Hill, Guarino, Barone, Rondelli, Kleinig, Cornell-Farrow, Krause, Wronski, Singhal, Ma and Phan.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Andy Lim (A)

School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia.

Peter M Rothwell (PM)

Wolfson Center for the Prevention of Stroke and Dementia, Nuffield Department of Clinical Neuroscience, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.

Linxin Li (L)

Wolfson Center for the Prevention of Stroke and Dementia, Nuffield Department of Clinical Neuroscience, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.

Shelagh B Coutts (SB)

Departments of Clinical Neurosciences, Radiology and Community Health Sciences, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.

Michael D Hill (MD)

Departments of Clinical Neurosciences, Radiology and Community Health Sciences, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.

Maria Guarino (M)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

Valentina Barone (V)

Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.

Francesca Rondelli (F)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

Timothy Kleinig (T)

Department of Neurology, Royal Adelaide Hospital, Adelaide, SA, Australia.

Reid Cornell-Farrow (R)

Department of Neurology, Royal Adelaide Hospital, Adelaide, SA, Australia.

Martin Krause (M)

Department of Neurology, Royal North Shore Hospital and Kolling Institute, University of Sydney, St Leonards, NSW, Australia.

Miriam Wronski (M)

Department of Neurology, Royal North Shore Hospital and Kolling Institute, University of Sydney, St Leonards, NSW, Australia.

Shaloo Singhal (S)

School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia.
Department of Neurology, Monash Health, Melbourne, VIC, Australia.

Henry Ma (H)

School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia.
Department of Neurology, Monash Health, Melbourne, VIC, Australia.

Thanh G Phan (TG)

School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia.
Department of Neurology, Monash Health, Melbourne, VIC, Australia.

Classifications MeSH